IP Library Granted Patent US 12,173,334
Granted Patent B2
US 12,173,334 · App. 17/537,419 · Granted Dec 24, 2024

Bio-engineered hyper-functional “super” helicases

Inventors: Taekjip Ha (Baltimore, MD); Sinan Arslan (Urbana, IL)
Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
C12N9/14C12N9/90C12Y306/04012C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,173,334
App. No.
17/537,419
Granted
Dec 24, 2024
Kind
B2
Abstract

Conformationally-constrained helicases having improved activity and strength are provided. Methods of making conformationally-constrained helicases having improved activity and strength are provided. Methods of using conformationally-constrained helicases having improved activity and strength are provided.

Claims (15)

1. A method of catalyzing an unwinding reaction of a double-stranded DNA, comprising contacting the double-stranded DNA with a conformationally-constrained helicase

wherein the conformationally-constrained helicase is selected from the group consisting of a Rep helicase from E. coli , a UvrD helicase from E. coli , a PcrA helicase from B. stearothermophilus , or a homolog thereof;

wherein the conformationally-constrained helicase comprises a first subdomain comprising a 1A or a 1B subdomain having a first amino acid and a second subdomain comprising a 2B subdomain having a second amino acid,

wherein the first amino acid corresponds to any one of positions 84-116 or 178-196 of the helicase amino acid sequence, relative to SEQ ID NO:32;

wherein the second amino acid corresponds to any one of positions 388-411, 422-444, and 518-540 of the helicase amino acid sequence, relative to SEQ ID NO:32;

wherein a side chain of the first amino acid is covalently crosslinked to a side chain of the second amino acid with a linker to form an active, conformationally-constrained helicase;

wherein said first amino acid is less than about 20 Å from said second amino acid when the helicase is in an active conformation, and

wherein the conformationally-constrained helicase comprises at least one degree of freedom less than a helicase that is not constrained as such.

2. The method of claim 1 , wherein the conformationally-constrained helicase is chemically crosslinked.

3. The method of claim 1 , wherein the conformationally-constrained helicase comprises SEQ ID NO:4 or SEQ ID NO:12.

4. The method of claim 1 , wherein the linker comprises an alkyl having a length in the range from C7 to C23.

5. The method of claim 1 , wherein the first amino acid is covalently crosslinked to the second amino acid by a disulfide bond or a chemical crosslinker.

6. The method of claim 5 , wherein the chemical crosslinker is a bis-maleimide crosslinker.

7. The method of claim 5 , wherein the chemical crosslinker has a length of from about 6 Å to about 25 Å.

8. The method of claim 1 , wherein the chemical crosslinker is selected from the group consisting of

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2024
From: HA, TAEKJIP; ARSLAN, SINAN
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 068372/0689 →
Continuity (3)
Continuation 15526905
Provisional Application 62079183 · Nov 13, 2014
Related Publication 20220259576A1 · Aug 18, 2022